# RPX Inc.

> RPX Inc. (주식회사 알피엑스) is a K-derma brand house in Seoul that runs DERMAGRID and RADIDERM. With formulas grounded in skin science and marketing driven by data, it grows its brands in-house, from concept to global expansion. RPX built its own AI system, RPX Formula Gate, to evaluate formula candidates against one standard. Its products are made by licensed Korean cosmetic manufacturers.

## At a glance

- Founded: 22 June 2026, Seoul. CEO Labin Kim (김라빈).
- Two brands: DERMAGRID (in development) and RADIDERM (live).
- Technology: RPX Formula Gate. Korean patent application No. 10-2026-0185990.
- 4 trademarks: DERMAGRID (Registered), RADIDERM (Published), ALOEZULENE (Published), MELAPASE (Filed).

## What RPX is

RPX is a K-derma brand house that runs DERMAGRID and RADIDERM. With formulas grounded in skin science and marketing driven by data, we grow our brands ourselves, from concept to global expansion.

1. **Formulas grounded in skin science.** We weigh each formula candidate from our manufacturers on ingredients, regulations and published evidence before deciding what goes into a product.
2. **Marketing driven by data.** We collect public ad and sales-rank data every day to read the market. We make and run our own ads and product pages.
3. **From concept to global expansion.** Brand planning, product development and our own online store are all handled in-house. We start in Korea and expand abroad from there.

## Brands

### DERMAGRID

DERMAGRID is a global derma skincare brand by RPX Inc., grounded in skin science. Each product is designed to answer exactly one skin concern. The first line, a serum and a cream for blemish-prone skin, is in development. Details: https://www.rpx.co.kr/en/brands/dermagrid.md

### RADIDERM

RADIDERM is a derma brand by RPX Inc. focused on dark spot care. Its Melapase line, a cream and an ampoule, is sold at the official store, radiderm.co.kr. Details: https://www.rpx.co.kr/en/brands/radiderm.md

## Technology: RPX Formula Gate

RPX Formula Gate is an internal system built by RPX. It evaluates the cosmetic formula candidates our manufacturers send us against one set of criteria, and records which formula was chosen and why. It has been in use since September 2026, starting with RADIDERM Melapase Intensive Cream. The method is the subject of Korean patent application No. 10-2026-0185990.

1. **Intake**: We receive formula candidates from the manufacturer. Whatever the format (spreadsheet, PDF or photo), ingredient names are matched to standard names.
2. **Evaluate**: Each candidate is checked against ingredient data, country-by-country restrictions and efficacy papers, scored item by item, and summarized in a report.
3. **Decide**: Candidates are compared side by side. We write down what was chosen, what was dropped, and why. The record is stored so that any later change would show.
4. **Feed back**: After launch, sales and user feedback go back into the evaluation criteria.

Details: https://www.rpx.co.kr/en/technology.md

## Company facts

| Item | Detail |
| --- | --- |
| Company | RPX Inc. |
| Legal name (Korean) | 주식회사 알피엑스 |
| CEO | Labin Kim (김라빈) |
| Founded | 22 June 2026 |
| Business registration no. | 758-86-04036 |
| Head office | 5F, Room 2466, 512 Yeoksam-ro, Gangnam-gu, Seoul, Republic of Korea |
| Business areas | Cosmetic brand development and sales, cosmetics wholesale and e-commerce, cosmetics R&D, IP licensing |
| Email | labin@rpx.co.kr |

## Read more

- [About](https://www.rpx.co.kr/en/about.md)
- [Brands](https://www.rpx.co.kr/en/brands.md)
- [Formula evaluation](https://www.rpx.co.kr/en/technology.md)
- [FAQ](https://www.rpx.co.kr/en/faq.md)
- [Contact](https://www.rpx.co.kr/en/contact.md)
- [한국어](https://www.rpx.co.kr/index.md)

---
Source: https://www.rpx.co.kr/en · 주식회사 알피엑스(RPX Inc.)